NDC11 71767010001
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 71767-0100-01 | 71767-0100 |
| 71767-0100-1 | 71767-0100 |
| 71767-100-01 | 71767-100 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FUROSCIX | FUROSEMIDE INJECTION 80 MG/ 10 ML | scPharmaceuticals Inc., a wholly owned subsidiary of MannKind Corporation | eac958dd-8d43-e44e-e053-2995a90a4d5e | 2026-07-31 | Warnings, Adverse reactions | 71767-100-01 71767-100 71767010001 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.